US Patent Issued to Uniwersytet Warszawski, Explorna Therapeutics Sp. z on Sept. 29 for "MRNA 5'-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide" (Polish Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,261, issued on Sept. 29, was assigned to Uniwersytet Warszawski (Warsaw, Poland) and Explorna Therapeutics Sp. z o.o. (Warsaw, Poland).

"MRNA 5'-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide" was invented by Marcin Warminski (Warsaw, Poland), Pawel Sikorski (Warsaw, Poland), Joanna Kowalska (Warsaw, Poland) and Jacek Jemielity (Warsaw, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to new 5'mRNA end cap analogs, RNA molecules containing them, their uses and methods for their in vitro synthesis, as well as a method ...